Research Reflections: Sarcoma Experts Consider Emerging Evidence for Novel Combos

Season 3 Episode 21  ·  Jul 16, 2020, 08:09 PM

Headliner
Share
Subscribe

In our exclusive interview, Dr. Sen and Dr. Groisberg highlight research evaluating checkpoint inhibitors and combination chemotherapy regimens in the evolving sarcoma treatment paradigm.

Share
Subscribe
Next
FDA Approval Insights: Selpercatinib in RET+ NSCLC and Thyroid Cancers
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air